4,0
2 dic 2022
Dipendente attuale, più di 3 anni
Tarrytown, NY
Consiglia
Gradimento del CEO
Pronostico commerciale
Vantaggi
High quality science in most areas, aiming to address diseases where the is great need. Employees are paid and treated well.
Svantaggi
Losing the spirit of a biotech and feeling more like big pharma in some areas. Decision making and hiring often driven by VP-level folks in domains where they lack expertise (instead of the actual scientists). Lots of meetings. Too many managers.